Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
The Journal of Biological Chemistry
|
September 5, 2020
Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells
Abigail Allen, David Gau, Paul Francoeur, et al.
Cancer Immunology, Immunotherapy : CII
|
December 23, 2022
BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study
Jana Friedhoff, Felix Schneider, Christina Jurcic, et al.
Diagnostics (Basel, Switzerland)
|
April 13, 2024
PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept Study
Philipp Reimold, Georgi Tosev, Adam Kaczorowski, et al.
The Journal of Pathology
|
January 21, 2012
Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment
Vanessa Rausch, Li Liu, Anja Apel, et al.
Scientific Reports
|
May 18, 2022
Targeting the translational machinery in gastrointestinal stromal tumors (GIST): a new therapeutic vulnerability
Donna M Lee, Angela Sun, Sneha S Patil, et al.
Urologic Oncology
|
July 18, 2020
Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53
Adam Kaczorowski, Yanis Tolstov, Michael Falkenstein, et al.
Cancer Immunology, Immunotherapy : CII
|
September 25, 2019
The BRCA2 mutation status shapes the immune phenotype of prostate cancer
Maximilian Jenzer, Peter Keß, Cathleen Nientiedt, et al.
Urologic Oncology
|
July 30, 2021
Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer
Cathleen Nientiedt, Jan Budczies, Volker Endris, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
The Journal of Biological Chemistry
|
September 5, 2020
Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells
Abigail Allen, David Gau, Paul Francoeur, et al.
Cancer Immunology, Immunotherapy : CII
|
December 23, 2022
BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study
Jana Friedhoff, Felix Schneider, Christina Jurcic, et al.
Diagnostics (Basel, Switzerland)
|
April 13, 2024
PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept Study
Philipp Reimold, Georgi Tosev, Adam Kaczorowski, et al.
The Journal of Pathology
|
January 21, 2012
Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment
Vanessa Rausch, Li Liu, Anja Apel, et al.
Scientific Reports
|
May 18, 2022
Targeting the translational machinery in gastrointestinal stromal tumors (GIST): a new therapeutic vulnerability
Donna M Lee, Angela Sun, Sneha S Patil, et al.
Urologic Oncology
|
July 18, 2020
Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53
Adam Kaczorowski, Yanis Tolstov, Michael Falkenstein, et al.
Cancer Immunology, Immunotherapy : CII
|
September 25, 2019
The BRCA2 mutation status shapes the immune phenotype of prostate cancer
Maximilian Jenzer, Peter Keß, Cathleen Nientiedt, et al.
Urologic Oncology
|
July 30, 2021
Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer
Cathleen Nientiedt, Jan Budczies, Volker Endris, et al.
Page
of 3